Late Star Trek creator’s family donates $1M to heart disease research
John E. Kaye
- Published
- News, Technology, Uncategorized

Star Trek creator Gene Roddenberry’s family has donated $1million to cardiovascular research in the hope that more people really will live long and prosper
The cash is funding the development of a tricorder-like scanner – used by Dr McCoy in the TV series – that can detect heart disease with “unprecedented accuracy”.
U.S tech firm iCardio.ai was awarded the money by The Roddenberry Foundation as part of its million-dollar prize fund for start-ups that “use AI to improve the world”.

The Foundation was established in Gene’s honour after he died of cardiac arrest in 1991.
iCardio plans to use the winnings to scale-up its echocardiography technology and treat more people in rural and deprived areas.
Gene’s son Rod said his father’s dream to eradicate heart disease had taken a step closer to reality.
He said: “iCardio.ai’s groundbreaking technology has the potential to save millions of lives, making it a well-deserved recipient of the Roddenberry Prize.
“We’re inspired by Star Trek to boldly go towards a future where today’s diseases are easily detectable and preventable, and it’s an honour to continue my father’s legacy by supporting medical advancements that will make this future a reality.”
The biennial Roddenberry Prize is open to early-stage ventures — including nonprofits and for-profits — across the globe that create “positive, lasting change”.
Its latest competition, launched in 2024, focused on using AI and machine learning. Entrants needed to demonstrate that “AI can benefit society towards a more equitable, sustainable, and inclusive world”.
The prize is administered by The Roddenberry Foundation, which was founded after Gene’s death and now supports “extraordinary people who can change the world”.
This year’s winner, iCardio.ai, scooped $1million thanks to its cutting-edge ultrasounds that use AI to improve the speed and accuracy of cardiovascular diagnosis.
According to the Foundation, iCardio’s technology is similar to the fictional ‘tricorder’ handheld device seen across the Star Trek franchise.
In the TV series, a tricorder detects injuries, vital signs, and “dangerous organisms” by scanning patients’ bodies.
It was used by Dr ‘Bones’ McCoy to diagnose medical conditions, often when he was beamed down to a new planet.
Joseph Sokol, co-founder and CEO of LA-based iCardio.ai, said: “We are honoured to receive the Roddenberry Prize.
“This award will enable us to scale our technology to reach more people, particularly those in regions where cardiovascular care is lacking.
“Our goal is to empower clinicians with knowledge about their patient and, ultimately, drive higher quality care in patients suffering from cardiovascular disease.”
Biotech start-up Noetik also received a $250,000 grant from this year’s Roddenberry Prize to accelerate its work in cancer immunotherapy.
The original Star Trek series premiered in September 1966 and has spawned over 700 TV episodes, 14 movies and comic books, and countless animated series and homages.
Its creator, Gene, a former World War II bomber pilot, is known as the godfather of science fiction whose work inspired countless other franchises including Star Wars.
He introduced the concept and the power of AI to the public long before it gained mainstream popularity, through storylines and characters including interactive computers and medical holograms capable of autonomously treating patients.
Gene later became the first TV writer with a star on the Hollywood Walk of Fame, while his legacy also includes having both a crater on Mars and an asteroid named in his honour.
In 1976, NASA invited Gene and the Star Trek crew to the rollout of the Enterprise space shuttle at the Dryden Flight Research Center.
Years after his death, he was one of the first humans to have his ashes carried into earth orbit.
Main image: Courtesy, NASA
In this image, the then Dryden Flight Research Center (now Armstrong) hosted the Star Trek crew in 1976 for the rollout of space shuttle Enterprise. In front, from left: NASA Administrator James Fletcher, and the show’s stars DeForest Kelley, George Takei, Nichelle Nichols, Leonard Nimoy, show creator Gene Roddenberry, and Walter Koenig.
TOP STORIES
-
Russia takes control of more European corporate assets amid Ukraine tensions -
EU leaders resist calls to delay carbon rules as energy costs soar -
‘A big step forward’ – PM Andy Burnham hails plans for Great British Railways HQ in Derby -
UK economy grows just 0.1 per cent as construction falls and services stall -
Germany risks losing €155bn a year under tighter AI data rules, new study warns -
Pope Leo XIV diagnosed with lung cancer after surgery in Rome -
France faces freezer meltdown as hackers strike supermarket chains -
Bumble shares soar 50% amid $1bn takeover talks -
China slump drives Volkswagen to sharpest quarterly fall in more than four years -
Hollywood mega-powerhouse created as Paramount completes Warner Bros Discovery takeover -
Gamers face gridlock as latest Grand Theft Auto download 'nears two days' -
Samsung profits soar ninefold to record £61bn amid AI chip boom -
New Springer books put the UN’s struggling sustainability goals to the real-world test -
Europe’s solar boom set for two-year slowdown after record growth -
Let it pea. Musicians turn vegetables into instruments at Beatles' Abbey Road studios -
Golden naked Trump statue unveiled at European Parliament -
Jaguar puts controversial rebrand on the road with £130K 1,030PS Type 01 -
Deepfakes and identity fraud drive new wave of post-hire background checks -
Spain crowned Europe’s top retirement destination -
More than half of UK professionals report workplace burnout -
More than 1.2m English drivers may have eyesight too poor for the road, study finds -
David Reuben, Britain’s second richest person, leaves London for Monaco -
UK prisoner release plan faces a major lag as tougher rules risk sending inmates back to jail -
Brits trust AI with their health but not their money -
Britain still hungry for Italian food as exports hit €4.56bn despite Brexit




























